MedDataX Logo

Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy

NCT03388151 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-08-27

No results posted yet for this study

Summary

propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy

Conditions

  • Cirrhosis, Liver

Interventions

DRUG

Midazolam

Midazolam 3 mg i.v added to fentanyl 0.5 ug/kg till reaching satisfactory level of sedation

DRUG

Propofol

Propofol 1 mg/kg i.v added to fentanyl 0.5 ug/kg i.v till reaching satisfactory level of sedation

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Sherief Abd-Elsalam, MD · Gastroenterology

  • Sameh Abdelkhalek Ahmed, MD · Tanta University Anasthesia Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2022-11-11
Completion
2022-12-11

Countries

  • Egypt

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388151 on ClinicalTrials.gov